Skip to content
Search

Latest Stories

A glimpse of Ahmedabad’s heritage through the lens of Pino Shah

by ASJAD NAZIR

HE MAY have been living in USA for more than 30 years, but Deval ‘Pino’ Shah never disconnected himself from his roots in Ahmedabad in India.


The Texas based world heritage photographer took more than 20,000 images of Ahmedabad and selected 950 of them for a fascinating new book. His book Ahmedabad: Glimpses of India’s First World Heritage City, written under his pen name Pino Shah, is a tribute to the city.

Eastern Eye caught up with Pino Shah to find out more about the book and Ahmedabad.

What inspired you to put this book together?

I was born in Ahmedabad and when UNESCO designated it as a World Heritage City in July 2017, I knew it was time to publish my photographs into a book.

What was the starting point for the book?

From October of 2009 to March of 2010, I had moved back to Ahmedabad after living in the US for 22 years. At that time, I started architectural photography and took pictures of the old city.

You took over 20,000 photos. How did you narrow down the images?

First, I decided on the outline for the book and asked myself, what did I want someone who had never visited Ahmedabad to know? What did I want to showcase about the old city? Heritage to me encompasses culture, tradition, including festivals, the way people dress, music, food, architecture, etc. So, I wanted to visually show the world Ahmedabad’s heritage. Then, it was a matter of finding photographs from my collection for the topics outlined and deciding which ones told a story. Finally, after looking at all the images, would a person want to visit Ahmedabad? This helped me select the images.

Is there one image that means the most to you?

There are several that speak to me. I love architecture, especially, historic architecture, but it is only people that make a structure meaningful. There is one of a man with a heavy heart praying – his body language and facial expressions say it all. It is a glimpse of an intimate conversation between the creator and his child.

What new thing did you learn about Ahmedabad?

I did not know how rich the architectural treasures dating back to 1400s were, though I grew up in the city.

Who are you hoping connects with the book?

The world, especially children and grandchildren of NRIs who have probably heard stories about the old city. Now, they can get a comprehensive overview of what a 600-year-old city is like. How folks still live in over 100-year-old houses.

What can we expect next from you?

I am headed to Ahmedabad for three weeks in February after a week in Abu Dhabi (working on updating my book on Sheikh Zayed Grand Mosque). I have been debating

about doing a similar book on Mumbai, though it doesn’t have as many historic buildings. Perhaps, a similar book on historic architecture in Gujarat.

Another book that you like...

The Bible.

What inspires you?

I share a very close relationship with the almighty. I recognise the talents he has bestowed upon me. That is what inspires me to work on such projects almost single-handedly. In the last three years, I have been blessed to have published six books on historic architecture. Something like that only happens when blessings are in abundance, not solely due to talent.

www.artbypino.com & Facebook: @artbypino

More For You

Shefali Jariwala

Glutathione and anti ageing drugs under spotlight after Shefali Jariwala death

Instagram/shefalijariwala

Did anti-ageing pills, beauty supplements and glutathione trigger Shefali Jariwala’s death?

Quick highlights:

  • Shefali Jariwala died at 42 in Mumbai after reportedly collapsing post-fast; cause of death suspected to be cardiac arrest or blood pressure drop.
  • Police found anti-ageing pills, vitamin supplements, and glutathione injections at her residence.
  • Doctors stress the risks of unsupervised use of hormone-based and anti-ageing treatments.
  • Final post-mortem report expected in two days; no foul play suspected, case treated as accidental death.

The untimely death of actor-model Shefali Jariwala has sparked renewed concern over the unregulated use of anti-ageing treatments and self-medication. The 42-year-old, best known for her appearance in Kaanta Laga, was declared dead on arrival at a Mumbai hospital on Friday night. Initial investigations suggest she may have suffered a cardiac arrest following a steep drop in blood pressure, possibly linked to taking supplements on an empty stomach.

Keep ReadingShow less
Prada 2026 sandals

Prada acknowledges Indian influence behind its Spring Summer 2026 men’s footwear

Instagram/prada/iStock

Prada finally acknowledges Kolhapuri chappals inspired 2026 sandals after Indian backlash over Milan show

Quick highlights:

• Prada confirms Indian roots behind 2026 ‘leather sandals’ after controversy
• Indian artisans and officials accused the brand of cultural appropriation
• The footwear resembles traditional Kolhapuri chappals with GI status
• Prada says designs are still in development and open to dialogue with India

Keep ReadingShow less
Anna Wintour

Wintour’s style of leadership earned her the nickname “Nuclear Wintour”

Getty Images

Anna Wintour steps down as editor of US Vogue after 37 years

Key points

  • Anna Wintour steps down as editor of US Vogue after 37 years
  • She will remain Vogue’s global editorial director and hold senior roles at Condé Nast
  • Wintour transformed US Vogue into a global fashion authority
  • The 75-year-old has received numerous honours, including the Presidential Medal of Freedom

End of an era at US Vogue

Anna Wintour has stepped down as the editor of US Vogue, bringing to a close a 37-year tenure that redefined the publication and saw her become one of the most influential figures in global fashion.

The announcement was made on Thursday (26 June) during a staff meeting in New York. Wintour, 75, will no longer oversee the day-to-day editorial operations of Vogue’s US edition. However, she will continue to serve as Vogue’s global editorial director and Condé Nast’s chief content officer, maintaining senior leadership roles across the company.

Keep ReadingShow less
Nadiya Hussain

She also reassured her followers that “exciting” new projects are on the way

Getty Images

“I won’t always be grateful” says Nadiya Hussain after BBC axes her cookery show

Key points

  • Nadiya Hussain confirms BBC will not renew her cookery series
  • Bake Off winner challenges expectations to remain “grateful”
  • She says hard work and talent, not luck, brought her success
  • Celebrities, including Annie Lennox and Fearne Cotton, show support

BBC ends decade-long collaboration with Bake Off star

Nadiya Hussain has spoken out after the BBC decided not to commission another cookery programme with her. The popular TV chef, who won The Great British Bake Off in 2015, shared her views on social media, stating that she “won’t always be grateful” and should not be expected to remain silent about career setbacks.

The decision ends a nearly 10-year working relationship between the broadcaster and Hussain, who has hosted several well-received cookery shows under the BBC banner. In her latest Instagram video, she addressed the public’s reaction and emphasised her right to expect more from her career.

Keep ReadingShow less
weight loss injections UK

The importance of vigilance as demand for these weight loss and diabetes drugs continues to grow

iStock

Hundreds report pancreas issues linked to weight loss injections as UK launches safety study

Key points

  • Almost 400 reports of acute pancreatitis linked to weight loss and diabetes jabs have been filed in the UK
  • Most cases involve popular GLP-1 drugs including Ozempic, Wegovy, and Mounjaro
  • Health officials are investigating possible genetic causes behind the side-effects
  • Patients hospitalised with pancreatitis encouraged to report symptoms via MHRA’s Yellow Card scheme
  • Adverse drug reactions cost the NHS an estimated £2.2bn annually

Health watchdog investigates spike in serious side-effects from GLP-1 drugs

UK health authorities have launched a study into the side effects of popular weight loss and diabetes drugs following a spike in reported cases of acute pancreatitis. Nearly 400 reports have been received via the Medicines and Healthcare products Regulatory Agency’s (MHRA) Yellow Card scheme, which monitors side effects and adverse reactions related to medicines and medical devices.

The medicines involved are GLP-1 receptor agonists – including semaglutide (marketed as Ozempic and Wegovy), liraglutide, and tirzepatide (branded as Mounjaro). The Yellow Card data shows that 181 of the cases involved tirzepatide alone.

Keep ReadingShow less